Efficacy of Bimin decoction for patients with perennial allergic rhinitis: an open-label non-inferiority randomized controlled trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Efficacy of Bimin decoction for patients with perennial allergic rhinitis: an open-label non-inferiority randomized controlled trial ; volume:20 ; number:1 ; day:30 ; month:12 ; year:2019 ; pages:1-8 ; date:12.2019
Trials ; 20, Heft 1 (30.12.2019), 1-8, 12.2019
- Urheber
-
Zhao, Jingyi
Yan, Xinyu
Gai, Jianqing
Han, Jinshuai
Zhang, Hong
Luo, Hui
Huang, Shaoting
Wang, Junge
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13063-019-3763-z
- URN
-
urn:nbn:de:101:1-2020041023375771575397
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhao, Jingyi
- Yan, Xinyu
- Gai, Jianqing
- Han, Jinshuai
- Zhang, Hong
- Luo, Hui
- Huang, Shaoting
- Wang, Junge
- SpringerLink (Online service)
Ähnliche Objekte (12)
Through the looking glass: understanding non-inferiority
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology
Bayes factors for superiority, non-inferiority, and equivalence designs
Understanding the null hypothesis (H0) in non-inferiority trials
Demonstrating equivalence and non-inferiority of medical education concepts
Evidence-based sizing of non-inferiority trials using decision models
Restrictive diets are unnecessary for colonoscopy: Non-inferiority randomized trial
Potential role of “the compensating benefit” in claiming non-inferiority
Phase IV non-inferiority trials and additional claims of benefit
Superiority and non-inferiority: two sides of the same coin?
Is there a danger of “biocreep” with non-inferiority trials?
Through the looking glass: understanding non-inferiority
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology
Bayes factors for superiority, non-inferiority, and equivalence designs
Understanding the null hypothesis (H0) in non-inferiority trials
Demonstrating equivalence and non-inferiority of medical education concepts
Evidence-based sizing of non-inferiority trials using decision models
Restrictive diets are unnecessary for colonoscopy: Non-inferiority randomized trial
Potential role of “the compensating benefit” in claiming non-inferiority
Phase IV non-inferiority trials and additional claims of benefit
Superiority and non-inferiority: two sides of the same coin?
Is there a danger of “biocreep” with non-inferiority trials?
Through the looking glass: understanding non-inferiority
Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation
Non-efficacy benefits and non-inferiority margins: a scoping review of contemporary high-impact non-inferiority trials in clinical cardiology
Bayes factors for superiority, non-inferiority, and equivalence designs
Understanding the null hypothesis (H0) in non-inferiority trials
Demonstrating equivalence and non-inferiority of medical education concepts
Evidence-based sizing of non-inferiority trials using decision models
Restrictive diets are unnecessary for colonoscopy: Non-inferiority randomized trial
Potential role of “the compensating benefit” in claiming non-inferiority
Phase IV non-inferiority trials and additional claims of benefit
Superiority and non-inferiority: two sides of the same coin?